SANTA BARBARA, CA–(Marketwired – Feb 19, 2014) – USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce Jay Crowley will speak at the Medical Devices Summit. Crowley will be a panelist at the “Understanding and Implementing Unique Device Identification” session on Tuesday, February 25th at 1:10 pm.
“I am looking forward to helping medical device companies implement UDI in a way that not only achieves compliance, but helps them realize the global benefits of UDI,” said Crowley.
As Vice President of the UDI Practice at USDM Life Sciences, Crowley helps medical device manufacturers attain regulatory compliance as well as internal benefits and competitive advantage around UDI implementation.
Crowley spent nearly 27 years at FDA. Most recently, he was Senior Advisor for Patient Safety, in FDA’s Center for Devices and Radiological Health. Crowley had primary responsibility for the development and implementation of FDA’s Unique Device Identification System.
Crowley and USDM’s UDI team will also be available at the summit to discuss their UDI services and solutions.
The Medical Devices Summit is February 25-26, 2014 at the Boston Marriott Long Wharf in Boston, MA.
About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. USDM Life Sciences has more than 13 years of experience supplying our clients in the life science industry with compliance services during each phase of their drug and product development cycle while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. For more information, please visit www.usdm.com.
USDM Life Sciences